HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peroxisome proliferator-activated receptor-alpha reduces inflammation and vascular leakage in a murine model of acute lung injury.

Abstract
Acute lung injury (ALI) still represents a major cause of morbidity and mortality in intensive care units. Beneficial effects have been described after activation of the peroxisome proliferator-activated receptor (PPAR)-alpha by fibrates such as WY 14,643 (WY) in inflammatory models. In the present study, the impact of WY was investigated in a model of endotoxin (lipopolysaccharide; LPS)-induced ALI in mice. Intratracheal LPS challenge dose-dependently resulted in leukocyte invasion, protein leakage and release of tumour necrosis factor-alpha as well as macrophage inflammatory protein-2, prostaglandin E(2) and thromboxane B(2) into the alveolar space after 8 and 24 h. Lung ventilator compliance was reduced at both time-points. In isolated perfused mouse lungs, platelet-activating factor (PAF) induced an acute increase in pulmonary artery pressure (P(pa)) and in capillary filtration coefficient (K(fc)). WY significantly improved all features of ALI in vivo and blunted the increase in K(fc) in isolated perfused mice lungs. In mice with genetic deletion of PPAR-alpha, all characteristics of ALI, P(pa), and K(fc) were not significantly different from wild-type mice but WY failed to improve ALI and PAF-induced increase in K(fc). Activation of peroxisome proliferator-activated receptor-alpha by WY 14,643 reduced acute lung injury and vascular leakage. Fibrates may possess beneficial effects in acute pulmonary diseases beyond their lipid-lowering capability.
AuthorsM B Schaefer, A Pose, J Ott, M Hecker, A Behnk, R Schulz, N Weissmann, A Günther, W Seeger, K Mayer
JournalThe European respiratory journal (Eur Respir J) Vol. 32 Issue 5 Pg. 1344-53 (Nov 2008) ISSN: 1399-3003 [Electronic] England
PMID18653653 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endotoxins
  • Lipopolysaccharides
  • PPAR alpha
  • Peroxisome Proliferators
  • Platelet Activating Factor
  • Pyrimidines
  • pirinixic acid
Topics
  • Acute Lung Injury (drug therapy, pathology)
  • Animals
  • Capillaries
  • Disease Models, Animal
  • Endotoxins (metabolism)
  • Inflammation
  • Lipopolysaccharides (metabolism)
  • Mice
  • Mice, Transgenic
  • PPAR alpha (metabolism)
  • Peroxisome Proliferators (pharmacology)
  • Platelet Activating Factor (metabolism)
  • Pressure
  • Pulmonary Artery (pathology)
  • Pyrimidines (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: